Abstracts tagged "rehabilitation and systemic lupus erythematosus (SLE)"

Abstract Number: 2769 • 2017 ACR/ARHP Annual Meeting
Predictive Value of Leisure-Time Physical Activity in Women with Systemic Erythematosus Lupus on Physical and Mental Health
Alix St-Aubin¹, Anne-Sophie Julien², Carolyn Neville³, Ellie Aghdassi⁴, Stacey Morrison⁵, Jiandong Su⁶, Janet E. Pope⁷, Sara Hewitt⁸, Christian Pineau⁹, Paula Harvey¹⁰, Michal Abrahamowicz¹¹, Deborah Da Costa¹², Paul Poirier¹³ and Paul R. Fortin¹⁴, ¹Division of Rheumatology, Department of Medicine, CHU de Québec – Université Laval, Quebec, QC, Canada, ²CHU de Quebec - Universite Laval, Quebec City, QC, Canada, ³Department of Medicine, McGill University Health Center, Montreal, QC, Canada, ⁴Epidemiology Division, The Toronto Western Hospital, Toronto, ON, Canada, ⁵Rheumatology, Krembil Research Institute, Toronto, ON, Canada, ⁶Rheumatology, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ⁷Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ⁸Department of Medicine, Division of Rheumatology, University of Western Ontario, St-Joseph Health Care, London, ON, Canada, ⁹Rheumatology, McGill University Health Center, Montreal, QC, Canada, ¹⁰Cardiology, Women's College Hospital, University of Toronto, Toronto, ON, Canada, ¹¹Department of Medicine, McGill University Health Centre, Montreak, QC, Canada, ¹²Department of Medicine, McGill University Health Center, Montréal, Quebec, Canada., Montreal, QC, Canada, ¹³Deparment of Medicine, Division of Cardiology, Institut universitaire de cardiologie et de pneumologie de Québec and Université Laval, Quebec City, QC, Canada, ¹⁴Medicine, CHU de Quebec - Universite de Laval, Quebec, QC, Canada
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is associated with a higher mortality due to higher risk of cardiovascular events. Although…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].